8-K - Moleculin Biotech, Inc. (0001659617) (Filer)
Published . Updated .
Filed: 2026-10-09 AccNo: 0001437749-26-032455 Size: 342 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Directly affected
- MBRX Moleculin Biotech
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-09 AccNo: 0001437749-26-032455 Size: 342 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission o…
Source: sec-edgar
Moleculin Biotech (MBRX) since this story, compared with the market
Since the first closing price after “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Moleculin Biotech (MBRX) is -35.99%. The S&P 500 fund (SPY) is -1.47% over the same days, a -34.52% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +2.77% | final price |
| Acadia Healthcare (ACHC) | the next day | +3.30% | final price |
| Acadia Healthcare (ACHC) | two days later | +8.10% | final price |
| Acadia Healthcare (ACHC) | three days later | +6.05% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -0.10% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -1.26% | final price |
| Ascendis Pharma A/S (ASND) | that day | -1.02% | final price |
| Ascendis Pharma A/S (ASND) | the next day | -2.62% | final price |
| Ascendis Pharma A/S (ASND) | two days later | -0.97% | final price |
| Ascendis Pharma A/S (ASND) | three days later | -1.16% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | -0.44% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | -0.53% | final price |
| aTYR PHARMA (ATYR) | that day | -12.47% | final price |
| aTYR PHARMA (ATYR) | the next day | -19.29% | final price |
| aTYR PHARMA (ATYR) | two days later | -26.67% | final price |
| aTYR PHARMA (ATYR) | three days later | -25.18% | final price |
| aTYR PHARMA (ATYR) | three days earlier | +12.07% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +17.92% | final price |
| BridgeBio Pharma (BBIO) | that day | +0.57% | final price |
| BridgeBio Pharma (BBIO) | the next day | -3.13% | final price |
| BridgeBio Pharma (BBIO) | two days later | -0.59% | final price |
| BridgeBio Pharma (BBIO) | three days later | +2.72% | final price |
| BridgeBio Pharma (BBIO) | three days earlier | +1.75% | final price |
| BridgeBio Pharma (BBIO) | five days earlier | +1.28% | final price |
| Davita (DVA) | that day | +1.37% | final price |
| Davita (DVA) | the next day | +1.71% | final price |
| Davita (DVA) | two days later | +0.82% | final price |
| Davita (DVA) | three days later | +5.51% | final price |
| Davita (DVA) | three days earlier | -1.34% | final price |
| Davita (DVA) | five days earlier | -0.40% | final price |
Disclosure records for Moleculin Biotech (MBRX) within two months of 9 Oct 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 10 days before publication, inside 30 days. The filing is listed beside the story “8-K - Moleculin Biotech, Inc. (0001659617) (Filer).”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 28 days before publication, inside 30 days. The filing is listed beside the story “8-K - Moleculin Biotech, Inc. (0001659617) (Filer).”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Moleculin Biotech, Inc. (0001659617) (Filer)”
Companies tied to this story
- MBRX Moleculin Biotech
In “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Moleculin Biotech (MBRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MBRX
- ACHC Acadia Healthcare
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “8-K - Moleculin Biotech, Inc. (0001659617) (Filer),” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” reaches Moleculin Biotech (MBRX)
“8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” (9 Oct 2026) reaches Moleculin Biotech (MBRX) through this story.
The link for Moleculin Biotech (MBRX) is this: SEC 8-K filing -> direct issuer disclosure -> MBRX
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Moleculin Biotech (MBRX)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. MBRX traded between 0.23 and 0.45 across 7 sessions. The latest close on file is 0.26.
How solid “8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” looks
46 out of 100
“8-K - Moleculin Biotech, Inc. (0001659617) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.